Sycamore Partners Completes Acquisition of Walgreens Boots Alliance, Taking Pharmacy Giant Private
ByAinvest
Thursday, Aug 28, 2025 4:24 pm ET1min read
WBA--
The acquisition was executed in partnership with Stefano Pessina and his family, who reinvested 100% of their interests in WBA, demonstrating their ongoing support and confidence in the company's future [1]. Sycamore Partners, led by Managing Director Stefan Kaluzny, expressed enthusiasm for the partnership, highlighting the essential role WBA plays in communities worldwide [1].
Stefano Pessina, in a statement, underscored the significance of this milestone, stating, "This begins a new chapter for Walgreens, The Boots Group, and the other portfolio businesses. Our family has proudly supported these companies for decades, and we are pleased to continue that commitment alongside Sycamore" [1].
Following the acquisition, Walgreens, The Boots Group, Shields Health Solutions, CareCentrix, and VillageMD will operate as separate standalone companies. WBA shareholders received a total consideration of $11.45 per share in cash at closing, along with a non-transferable right to receive up to an additional $3.00 in cash per share from the future monetization of WBA’s debt and equity interests in VillageMD [2].
The acquisition is subject to customary closing conditions, including approval by WBA shareholders and regulatory approvals. The transaction agreement includes a "go-shop" period, during which WBA can actively solicit alternative proposals. The initial go-shop period is 35 days [2].
The deal has been advised by a range of financial and legal firms, including UBS Investment Bank, Goldman Sachs, J.P. Morgan, Citi, and Wells Fargo, among others. Sycamore Partners and WBA have each appointed legal counsel to manage the transaction [2].
In conclusion, the acquisition of Walgreens Boots Alliance by Sycamore Partners signifies a strategic shift for the pharmacy giant, moving it from a publicly traded entity to a private company. The transaction is expected to enhance operational flexibility and potentially unlock new opportunities for growth and innovation.
References:
[1] https://www.walgreensbootsalliance.com/news-media/press-releases/2025/sycamore-partners-completes-acquisition-walgreens-boots-alliance
[2] https://www.marketscreener.com/news/sycamore-partners-management-l-p-completed-the-acquisition-of-walgreens-boots-alliance-inc-from-s-ce7c50dcd98ff524
Walgreens Boots Alliance is now a private company after Sycamore Partners closed its acquisition deal. The pharmacy giant is no longer publicly traded on the stock market.
Walgreens Boots Alliance (WBA) has officially transitioned to private ownership following Sycamore Partners' acquisition, marking a significant shift in the global pharmacy giant's corporate structure. The acquisition, which closed on August 28, 2025, has resulted in WBA's common stock ceasing trading and its delisting from the Nasdaq Stock Market [1].The acquisition was executed in partnership with Stefano Pessina and his family, who reinvested 100% of their interests in WBA, demonstrating their ongoing support and confidence in the company's future [1]. Sycamore Partners, led by Managing Director Stefan Kaluzny, expressed enthusiasm for the partnership, highlighting the essential role WBA plays in communities worldwide [1].
Stefano Pessina, in a statement, underscored the significance of this milestone, stating, "This begins a new chapter for Walgreens, The Boots Group, and the other portfolio businesses. Our family has proudly supported these companies for decades, and we are pleased to continue that commitment alongside Sycamore" [1].
Following the acquisition, Walgreens, The Boots Group, Shields Health Solutions, CareCentrix, and VillageMD will operate as separate standalone companies. WBA shareholders received a total consideration of $11.45 per share in cash at closing, along with a non-transferable right to receive up to an additional $3.00 in cash per share from the future monetization of WBA’s debt and equity interests in VillageMD [2].
The acquisition is subject to customary closing conditions, including approval by WBA shareholders and regulatory approvals. The transaction agreement includes a "go-shop" period, during which WBA can actively solicit alternative proposals. The initial go-shop period is 35 days [2].
The deal has been advised by a range of financial and legal firms, including UBS Investment Bank, Goldman Sachs, J.P. Morgan, Citi, and Wells Fargo, among others. Sycamore Partners and WBA have each appointed legal counsel to manage the transaction [2].
In conclusion, the acquisition of Walgreens Boots Alliance by Sycamore Partners signifies a strategic shift for the pharmacy giant, moving it from a publicly traded entity to a private company. The transaction is expected to enhance operational flexibility and potentially unlock new opportunities for growth and innovation.
References:
[1] https://www.walgreensbootsalliance.com/news-media/press-releases/2025/sycamore-partners-completes-acquisition-walgreens-boots-alliance
[2] https://www.marketscreener.com/news/sycamore-partners-management-l-p-completed-the-acquisition-of-walgreens-boots-alliance-inc-from-s-ce7c50dcd98ff524

Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue



Comments
No comments yet